The University of Texas Medical Branch, Galveston, is actively recruiting participants for a clinical trial studying the safety and performance of a wearable echolocation device aimed at improving mobility for individuals with low vision. This innovative device employs parametric sound technology to help users navigate their surroundings more effectively. The trial marks a significant step forward in accessible medical device development.
In this article:
- What is being tested?
- Who will benefit?
- Who funds this trial?
- FAQ
- Key takeaways
- Disclaimer
- Clinical trial announcement link
What is being tested?
This trial focuses on a wearable echolocation device designed specifically for individuals with low vision. The device leverages parametric sound technology to provide acoustic cues that enhance spatial awareness and object detection. Clinical research will evaluate the functional outcomes, usability, and safety of the device in real-world scenarios.
Who will benefit?
The primary beneficiaries of this device are individuals experiencing low vision, including those with progressive visual impairments or blindness. By delivering precise sound-based orientation, the device aims to reduce risk during mobility tasks and improve quality of life. Beyond individuals, the findings may inform future medical device designs targeting sensory assistance.
Who funds this trial?
The study is sponsored by The University of Texas Medical Branch, Galveston, a leading institution in medical and clinical research. This sponsorship underscores institutional commitment to advancing solutions for visually impaired populations. Further information is available via the ClinicalTrials.gov record linked below.
FAQ
- 1. What is parametric sound technology?
Parametric sound technology uses highly directional acoustic waves to create audible signals that help individuals identify surroundings more precisely. - 2. Who qualifies for participation?
Eligibility criteria typically include adults with low vision as defined by clinical standards. Interested participants should consult the trial coordinators. - 3. When is the study expected to conclude?
The recruitment phase is active, and timeline updates will be shared via official trial platforms.
Key takeaways
The wearable echolocation device under investigation represents a promising advancement in the realm of assistive technologies for visually impaired individuals. Clinical verification of safety and performance will provide essential insights into its utility for broader adoption. Stakeholders in clinical, regulatory, and quality sectors are encouraged to monitor developments.
Disclaimer
This article is provided for informational purposes only and does not constitute regulatory, clinical, or legal advice. Readers should consult official sources and experts for specific guidance.
Clinical trial announcement link
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07218991?term=medical+device